CorMedix
CRMD
190 hedge funds and large institutions have $502M invested in CorMedix in 2025 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 91 increasing their positions, 28 reducing their positions, and 33 closing their positions.
225% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 28
55% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 33
19% more capital invested
Capital invested by funds: $421M → $502M (+$80.7M)
10% more funds holding
Funds holding: 172 → 190 (+18)
4.88% more ownership
Funds ownership: 50.37% → 55.24% (+4.9%)
5% more call options, than puts
Call options by funds: $18.6M | Put options by funds: $17.7M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$40.2M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$10.8M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$9.85M |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
+$9.36M |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
+$6.83M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nuveen
Charlotte,
North Carolina
|
-$9.35M |
| 2 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$9.24M |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$8.93M |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$5.44M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$5.12M |
CRMD Hedge Fund Activity: Q3 2025 in Review
190 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q3 2025, worth a combined $502M — up 19% from $421M a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new CRMD positions and 33 closed out — a net gain of 18 holders — while 91 added to existing stakes and 28 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $40.2M. The largest seller was Nuveen, cutting an estimated $9.35M.
- 190 institutional investors held CorMedix (CRMD) as of Q3 2025, up from 172 in Q2 2025.
- Funds reported $502M of CorMedix stock for Q3 2025, up 19% quarter-over-quarter.
- 51 funds opened new CorMedix positions in Q3 2025 and 33 closed out, a net change of +18 holders.
- The largest CorMedix buyer in Q3 2025 was Deerfield Management, an estimated $40.2M added.
- The largest CorMedix seller in Q3 2025 was Nuveen, an estimated $9.35M sold.
Based on aggregated 13F filings for Q3 2025.